Latest filing published 31 May 2024 for Shockwave Medical, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Sara Toyloy in Shockwave Medical, Inc., where the filings describe the role as board member. In total, 8 filings cover trades dated from 24 March 2021 to 31 May 2024.
No open-market purchase appears, only 3 sales worth €211k. The rest of the record consists of 4 share grants.
On 31 May 2024 came the latest disclosure, a transaction in Shockwave Medical, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations